Oramed Pharmaceuticals Inc

Oramed CEO Secures 167k RSUs Amid Executive Buying Surge—Signals Bullish Outlook for Oral Insulin Launch

Oramed insiders boost confidence: CEO Nadav’s RSU award and executive buying signal strong alignment with upcoming oral insulin launch, hinting at future upside.

Oramed Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

19/03/2026, 00:20

4 minutes to read

Oramed Executives Flip the Switch: CFO Avraham’s First RSU Grant Signals Bullish Future, Amid Mixed Insider Trades and Rising Stock Price

Oramed’s new RSU grants signal management’s confidence, boosting investor optimism about its oral‑insulin platform’s future upside.

Oramed Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

19/03/2026, 00:04

3 minutes to read